hydroxychloroquine

hydroxychloroquine information and resources from the National Cancer Institute

hydroxychloroquine

A 4-aminoquinoline with antimalarial and immunosuppressive properties. Although its precise mechanism of action is unknown, hydroxychloroquine may suppress immune function by interfering with the processing and presentation of antigens and the production of cytokines. This agent is highly active against the erythrocytic forms of P. vivax and malariae and most strains of P. falciparum but not the gametocytes of P. falciparum. hydroxychloroquine

A 4-aminoquinoline with antimalarial and immunosuppressive properties. Although its precise mechanism of action is unknown, hydroxychloroquine may suppress immune function by interfering with the processing and presentation of antigens and the production of cytokines. This agent is highly active against the erythrocytic forms of P. vivax and malariae and most strains of P. falciparum but not the gametocytes of P. falciparum.

Aradigm begins midstage trial for asthma Mar 23, 2006
East Bay Business Times, The trial will study the safety and efficacy of an aerosolized formulation of hydroxychloroquine using Hayward-based Aradaigm's(NASDAQ: ARDM) pulmonary ...

Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program ... Mar 23, 2006
Market Wire (press release) ...a privately held biotechnology company, today announced the initiation of their Phase 2 clinical trial investigating aerosolized hydroxychloroquine (HCQ) as an ...

Aradigm and APT move asthma treatment into phase II Mar 24, 2006
Pharmaceutical Business Review ...and APT Pharmaceuticals, a privately held biotechnology company, have initiated a phase II clinical trial investigating aerosolized hydroxychloroquine, or HCQ ...

Ciphergen CFO quits, shares fall Mar 23, 2006
San Jose Mercury News, ...based APT Pharmaceuticals Inc., a privately held biotechnology company, began the second phase of clinical trial for aerosolized hydroxychloroquine, as an anti ...

Steroid treatment for arthritis ups pneumonia risk Mar 16, 2006
Reuters.uk, ...report in the medical journal Arthritis & Rheumatism that the most common treatments were methotrexate, prednisone, Remicade, hydroxychloroquine and Enbrel. ...

APT Pharmaceuticals Adds Vivo Ventures in Final Close of $9 ... Mar 21, 2006
Genetic Engineering News, The company is developing steroid-alternative therapies based on targeted administration of hydroxychloroquine (HCQ), a disease modifying antirheumatic drug ...

Arthritis drug that may help the worst cases Mar 20, 2006
Times Online, The tendency is to use the heavier treatment early: in the first instance, gold compounds, hydroxychloroquine, or sulfasalazin (better known to patients with ...

Immune system attacks body in lupus Mar 23, 2006
The Daily Athenaeum Interactive, ...prednisone (steroids), or other drugs that suppress the overactive immune system such as cyclophosphamide, methotrexate, hydroxychloroquine and intravenous ...

Rheumatoid Arthritis and Hearing Loss may be Unrelated Mar 6, 2006
Best Syndication, The researcher thought that possibly the prescription medicine hydroxychloroquine might have caused the hearing loss in some of the rheumatoid patients. ...

Arthritis Blog Archives Mar 6, 2006
About - News & Issues, Another possible connection may exist between hearing loss and some arthritis medications such as Plaquenil (hydroxychloroquine).

The Hearing Loss Risk and Rheumatoid Arthritis Link Mar 6, 2006
Ivanhoe, The study did show patients who took hydroxychloroquine were somewhat more likely to have hearing problems. The next step is to study this link further. ...

Rheumatoid Arthritis Does Not Increase Risk Of Hearing Loss, Mayo ... Mar 8, 2006
Medical News Today (press release), The researchers also noted a possible link between the hearing loss and rheumatoid arthritis medications, as patients who took hydroxychloroquine were somewhat ...

hydroxychloroquine -->